Prognostic Factors of AL-PCMM and AL-MM: A Single-Center Retrospective Study
Conclusion: ALP level, which is related to cardiac amyloidosis rather than liver involvement, can be a prognostic factor for this group of patients. A BU staging system stage ≥ III, ALP ≥ 187.5 IU/L, and ITE < VGPR were independent significant risk factors for a poor prognosis of AL-PCMM and AL-MM.PMID:35370457 | PMC:PMC8964324 | DOI:10.7150/ijms.61712
Source: International Journal of Medical Sciences - Category: Biomedical Science Authors: Junhui Xu Zhixiang Qiu Miao Yan Bingjie Wang Zhengyang Song Huihui Liu Mangju Wang Xinan Cen Source Type: research
More News: Amyloidosis | Bilirubin | Biomedical Science | Boston University | Brain | Liver | Myeloma | Neurology | Study | Urology & Nephrology